TTNP News Alert Titan Pharma Inc (TTNP) 0.5600 09/20/2014 18

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Titan Pharma Inc (TTNP) 0.5600 $TTNP

Titan Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Global Investment Conference
Marketwire - Wed Sep 03, 6:01AM CDT
Titan Pharmaceuticals, Inc. (OTCBB: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of opioid dependence, Parkinson's Disease, and other serious medical disorders, today announced that Titan President Sunil Bhonsle will present at the Rodman & Renshaw 16th Annual Global Investor Conference at the New York Palace Hotel in New York City on Sept. 10 from 9:35-10 a.m. The presentation will take place in the Kennedy II Salon.

IPOs and Transactions: August 25 - 29
PR Newswire - Tue Sep 02, 12:57PM CDT
Vintage, the regulatory compliance and shareholder communications division of PR Newswire, has released its weekly IPO and Transaction summary.

Titan Pharmaceuticals Announces Second Quarter 2014 Financial Results
Marketwire - Wed Aug 13, 6:01AM CDT
Titan Pharmaceuticals, Inc. (OTCBB: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of opioid dependence and other serious medical disorders, today reported financial results for the second quarter ended June 30, 2014.

Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2014 Financial Results
Marketwire - Thu Aug 07, 6:00AM CDT
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) today announced that it will host a live conference call at 10 a.m. PT / 1 p.m. ET on Thursday, Aug. 14, 2014 to discuss the company's financial results as of June 30, 2014. The call will be hosted by Sunil Bhonsle, president; Katherine Glassman-Beebe, Ph.D., executive vice president and chief development officer; Brian Crowley, vice president of finance, and Marc Rubin, M.D., executive chairman. Highlights of the second quarter and financial results will be included in a press release to be issued prior to the call.

Titan Pharmaceuticals Announces First Patient Enrollment in Clinical Study of Probuphine for Opioid Dependence
Marketwire - Mon Jul 21, 6:00AM CDT
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) today announced enrollment of the first patients in the Phase 3 clinical study to support resubmission of the New Drug Application (NDA) for Probuphine(R), the company's investigational subdermal implant for the maintenance treatment of opioid dependence. The study, which is expected to be completed by the middle of 2015, is designed to address key questions posed by the U.S. Food and Drug Administration (FDA) in its complete response letter last year after review of the original NDA. Titan's partner Braeburn Pharmaceuticals is sponsoring the trial and anticipates resubmission of the NDA to the FDA in late 2015.

Highline Research Advisors Initiates on Titan Pharmaceuticals with a Buy Rating
Thomson Reuters ONE - Mon Jul 07, 9:44AM CDT
SAN FRANCISCO - July 7, 2014 -Michael Higgins from Highline Research Advisors, part of Financial Entrepreneur Platform at Merriman Capital, Inc. ("Merriman" , a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced today that it has initiated equity research coverage of Titan Pharmaceuticals, Inc. (OTCQB: TTNP) with a Buy rating and a $3.00 price target.

Titan Pharmaceuticals Announces Fourth Quarter and Year End 2013 Financial Results
Marketwire - Mon Mar 31, 6:02AM CDT
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) today reported financial results for the fourth quarter and year ended December 31, 2013.

Titan Pharmaceuticals Schedules Conference Call to Review Fourth Quarter and Full Year 2013 Financial Results
Marketwire - Wed Mar 26, 6:01AM CDT
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) today announced that it will host a live conference call at 10 a.m. PT / 1 p.m. ET on Tuesday, April 1, 2014 to discuss the company's financial results as of December 31, 2013. The call will be hosted by Sunil Bhonsle, president; Katherine Glassman-Beebe, Ph.D., executive vice president and chief development officer; Brian Crowley, vice president of finance, and Marc Rubin, M.D., executive chairman.

Titan Pharmaceuticals Announces Agreement in Principle on Path Forward for Probuphine Clinical Study
Marketwire - Mon Mar 03, 6:01AM CST
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) today announced that the company and its partner, Braeburn Pharmaceuticals, have agreed in principle with the U.S. Food and Drug Administration (FDA) on the design of a clinical study in support of the New Drug Application (NDA) for Probuphine(R), the company's investigational subdermal implant for the maintenance treatment of opioid dependence. The proposed clinical study will be a randomized, double blind and double dummy design that will provide information for a non-inferiority comparison of a six-month treatment with a dose of four Probuphine implants to treatment with 8mg or less of an approved daily dosed sublingual formulation of buprenorphine. Details of the study, including size and the data analysis plan, will be established following the FDA's review of a complete study protocol, which Braeburn expects to submit within the next two weeks.

CSE: 2014-0205-Name and Symbol Change-Synergy Acquisition Corp. (QMP)
Marketwire Canada - Wed Feb 12, 10:20AM CST
Synergy Acquisition Corp. has announced a name change to Genius Properties Ltd.

Spectra7 Announces Promotion Of Melissa Chee To Vice President Of Corporate Marketing And Product Management
PR Newswire - Tue Feb 04, 8:00AM CST
(TSX-V:SEV) Spectra7 Microsystems Inc. ("Spectra7" , a high performance analog semiconductor company delivering unprecedented speed, resolution and signal fidelity to consumer and wireless infrastructure products, today announced that Melissa Chee has been promoted to Vice President of Corporate Marketing and Product Management for the Company.

SecurityMetrics PCI Suite Named Finalist in Info Security Products Guide Global Excellence Awards
PR Newswire - Thu Jan 16, 12:18PM CST
Info Security Products Guide, the industry's leading information security research and advisory guide, has named SecurityMetrics PCI Suite a finalist for the 10th Annual 2014 Global Excellence Awards in the PCI Compliance category. These prestigious global awards recognize security and IT vendors with advanced products and solutions that help set the bar higher for others in all areas of security and technology.

Esri's Location Platform Brings the Power of Place to Microsoft Dynamics CRM
PR Newswire - Tue Jan 07, 1:45PM CST
Esri today announced the release of an enhanced Esri Maps for Microsoft Dynamics CRM. The software adds new analytical perspectives for retailers across the omni-channel. From a single store to the entire supply-chain, users can collaborate to author and share analytical intelligence on customers, stores, products, markets, and the competition with a wealth of demographic data for 120 countries.

Cambridge University Press picks DayNine Consulting management tool
M2 - Wed Dec 18, 8:25AM CST
Workday (NYSE: WDAY) services partner DayNine Consulting said it was selected by Cambridge University Press to deploy its Workday Human Capital Management solution.

Titan Pharmaceuticals Announces Submission of FDA Meeting Request Regarding Probuphine
Marketwire - Wed Sep 04, 6:01AM CDT
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) today announced the submission of a Type B meeting request to the U.S. Food and Drug Administration (FDA) to discuss Probuphine(R), the company's investigational subdermal implant designed to deliver continuous, blood levels of buprenorphine for six months following a single treatment.

Titan Pharmaceuticals Announces Publication of Phase 3 Probuphine Data in Addiction
Marketwire - Tue Aug 13, 4:03PM CDT
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) today announced that data from its previously completed and announced Phase 3 placebo- and active drug-controlled confirmatory clinical study of Probuphine(R), evaluating the safety and efficacy of its subdermal implant for the maintenance treatment of opioid dependence in adult patients, were published online in the journal Addiction. The paper is expected to appear in a future print issue of the journal.

Titan Pharmaceuticals Announces Amendment to Partnership With Braeburn Pharmaceuticals
Marketwire - Wed May 29, 3:05PM CDT
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) announced today that it has entered into an amendment to its license agreement with Braeburn Pharmaceuticals Sprl for the exclusive commercialization rights in the U.S. and Canada to the investigational product Probuphine(R), a novel, subdermal implant and the first long-acting product designed to deliver six months of the drug buprenorphine following a single treatment. The amendment primarily modifies certain of the agreement's termination provisions by providing Braeburn the right to terminate the license in the event significant additional clinical work or a material change to the product label will be required by the U.S. Food and Drug Administration (FDA) as a condition to approval of the New Drug Application (NDA) or if the NDA is not approved by June 30, 2014.

Titan Pharmaceuticals Inc swings to net income of USD6.0m for Q1 2013
M2 - Thu May 16, 8:30AM CDT
Biopharmaceutical company Titan Pharmaceuticals Inc (OTCBB:TTNP) stated on Wednesday its net income of USD6.0m (USD0.08 per share) for the first quarter ended 31 March 2013.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rox Taps Dynamics 365 Without Forcing a CRM Reset Yet

Updated Category News Views 27

Enterprise software buyers hate renovations when a useful extension will do. Rox’s new integration with Microsoft Dynamics 365 Sales, announced November 19, 2026, is built around that unglamorous but very real fact. The company is not asking a Global 2000 sales organization to rip out its customer system, retrain everybody, and pray an AI layer somehow pays for the...

Continue Reading
Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 77

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Color Me Mine Tests Florida's Creative Leisure Demand

Updated Category News Views 72

Pottery studios are not exactly the sort of thing that makes markets pound the table, but Florida’s latest Color Me Mine push deserves a closer look. The company signed three franchise agreements in 2026 for Panama City Beach, Doral and Boca Raton, adding planned growth to a state where it already operates 11 studios. For a private franchisor, this is not a quarterly...

Continue Reading
SK hynix Faces Fresh DRAM Collusion Risk for Investors

Updated Category News Views 66

A Memory Market Win Can Turn Sour Fast Nothing rattles a chip story quite like the word collusion showing up beside a judge’s ruling. SK hynix had been riding a powerful memory-market narrative, but investors got a blunt reminder on November 15, 2026: a proposed U.S. class action accusing SK hynix, Samsung Electronics, and Micron of restricting DRAM supply to raise...

Continue Reading
DJI Puts 3D Conservation Tools to Work Across Segovia

Updated Category News Views 33

Stone monuments do not care about marketing slogans; they care whether somebody notices the crack before winter gets hold of it. That is why DJI’s World Heritage 3D Conservation Initiative in Segovia lands as more than a shiny drone-company ceremony. The company gathered winning 3D fly-through work from its first initiative, but the useful bit was the case for turning...

Continue Reading
iFLYTEK’s AINOTE Discounts Put E-Ink Utility on Trial

Updated Category News Views 117

A slim E-Ink notebook is getting shoved into the Black Friday brawl, and iFLYTEK is betting that less screen glare and more follow-through can still command a serious price. The company has put discounts of up to 25% on its AINOTE lineup, a sensible move in a gadget season where buyers have no shortage of tablets, voice apps, and half-used productivity subscriptions...

Continue Reading
WYBOT's New Robots Push Hands-Free Pool Care in Lyon

Updated Category News Views 115

A pool robot climbing out of the water to dock itself is the sort of demo that makes people stop mid-aisle at a trade show. WYBOT brought precisely that kind of attention-grabber to Piscine Global Lyon 2026, running November 17–20 at Eurexpo Lyon. The company is showing a broader lineup, but the M3 Pro is plainly the headline act: WYBOT calls it the world's first...

Continue Reading
Receipts Turns Vegas Party Shirts Into AR Keepsakes

Updated Category News Views 101

A shirt that coughs up a Vegas weekend when scanned is either a smart little keepsake trick or a privacy headache wearing sequins. Receipts™, introduced by Las Vegas-based Naked City Couture and the AR Trading Card Company, is betting it can be the former. The concept is simple enough: friends wear the apparel, capture photos and videos during a trip, upload those...

Continue Reading
Honda Prelude’s Hybrid Return Tests a Narrow Niche

Updated Category News Views 0

A low-slung coupe showing up in Newfoundland is not exactly a volume-sales thunderclap, and that is precisely why the 2027 Honda Prelude deserves a closer look. Steele Honda in St. John’s is presenting the hybrid two-door as a fresh choice for buyers who want something livelier than the usual practical commuter. For Honda, and for investors watching Honda Motor Co....

Continue Reading
Ajman Forum Puts Algorithmic Messaging Under Scrutiny

Updated Category News Views 44

Algorithms do not merely shuffle posts anymore; they can scramble confidence in the institutions people depend on. That was the serious undercurrent at Ajman Media Forum 2026 – THE SIGNAL, where a session on who leads the government message in an algorithm-driven age brought the discussion back to an uncomfortable reality: communication, cybersecurity and social...

Continue Reading

Top 5 Most Recently Viewed Articles

WM Technology Faces Class Action Lawsuit: What Investors Need to Know

Updated Category News Views 69

Understanding WM Technology's Legal Challenges WM Technology, Inc. has recently found itself at the center of a class action lawsuit, raising significant concerns among its investors. This legal action has been initiated by a prominent law firm advocating for shareholder rights, highlighting serious allegations against the company. Investors are encouraged to stay...

Continue Reading
Nimbello's SyteLine Customer Growth Signals Bright Future Ahead

Updated Category News Views 224

Nimbello's Impressive Growth in the SyteLine Market Nimbello, renowned for its innovative Accounts Payable (AP) automation solutions, has achieved a significant milestone by doubling its customer base among SyteLine users throughout the year. This exciting growth showcases Nimbello's capability and positions it as a leader within the SyteLine ecosystem. Understanding...

Continue Reading
FRE Nicotine Pouches and PBR: A Thrilling Partnership Ahead

Updated Category News Views 169

FRE Nicotine Pouches and PBR: A Thrilling Partnership Ahead In an exciting development for sports enthusiasts, FRE® Nicotine Pouches has joined forces with Professional Bull Riders (PBR) as their official partner for the iconic Unleash The Beast event series. This remarkable multi-year sponsorship marks a significant milestone for FRE, making it their biggest sports...

Continue Reading
ADP Strengthens Workforce Management with WorkForce Software

Updated Category News Views 92

ADP Expands Its Workforce Management Solutions ADP (NASDAQ: ADP), a leading global technology company in human capital management (HCM) solutions, has made a significant move by acquiring WorkForce Software. This strategic acquisition aims to enhance ADP's workforce management offerings and bolster innovation to address the evolving needs of businesses worldwide....

Continue Reading
MiniLuxe Secures Funding through Innovative Private Placement

Updated Category News Views 305

MiniLuxe Announces a Strategic Private Placement MiniLuxe Holding Corp. has recently made headlines by initiating a non-brokered private placement aimed at raising up to $5 million. This move is geared toward furthering the company’s growth trajectory and expanding its footprint in the beauty and self-care industry. Offering Details and Investor Opportunities This...

Continue Reading